{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:55:35Z","timestamp":1791939335307,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Academy talent special fund of the First Affiliated Hospital with Nanjing Medical University","award":["YNRCQN0312"],"award-info":[{"award-number":["YNRCQN0312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12012-025-10001-x","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:37:59Z","timestamp":1745822279000},"page":"830-840","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Membrane Protein of SARS-CoV-2 Promotes the Production of CXCL10 and Apoptosis of Myocardial Cells"],"prefix":"10.1007","volume":"25","author":[{"given":"Xiaoguang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"issue":"12","key":"10001_CR1","doi-asserted-by":"publisher","first-page":"e24971","DOI":"10.1097\/MD.0000000000024971","volume":"100","author":"S Cheng","year":"2021","unstructured":"Cheng, S., Zhao, Y., Wang, F., Chen, Y., Kaminga, A. C., & Xu, H. (2021). Comorbidities\u2019 potential impacts on severe and non-severe patients with COVID-19: A systematic review and meta-analysis. Medicine, 100(12), e24971.","journal-title":"Medicine"},{"key":"10001_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s43657-022-00058-x","volume":"2","author":"JA Molina-Mora","year":"2022","unstructured":"Molina-Mora, J. A., Gonzalez, A., Jimenez-Morgan, S., Cordero-Laurent, E., Brenes, H., Soto-Garita, C., Sequeira-Soto, J., & Duarte-Martinez, F. (2022). Clinical profiles at the time of diagnosis of SARS-CoV-2 infection in Costa Rica during the pre-vaccination period using a machine learning approach. Phenomics, 2, 312\u2013322.","journal-title":"Phenomics"},{"issue":"11","key":"10001_CR3","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/j.hrthm.2020.06.026","volume":"17","author":"RD Mitrani","year":"2020","unstructured":"Mitrani, R. D., Dabas, N., & Goldberger, J. J. (2020). COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors. Heart Rhythm, 17(11), 1984\u20131990.","journal-title":"Heart Rhythm"},{"issue":"6","key":"10001_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B., Kamat, I., & Hotez, P. J. (2021). Myocarditis with COVID-19 mRNA vaccines. Circulation, 144(6), 471\u2013484.","journal-title":"Circulation"},{"issue":"12","key":"10001_CR5","first-page":"969","volume":"22","author":"MG Abrignani","year":"2021","unstructured":"Abrignani, M. G., Murrone, A., De Luca, L., Roncon, L., Di Lenarda, A., Valente, S., Caldarola, P., Riccio, C., Oliva, F., Gulizia, M. M., & Gabrielli, D. (2021). COVID-19, vaccines, and thrombotic events. Giornale Italiano di Cardiologia, 22(12), 969\u2013980.","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"17","key":"10001_CR6","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.jacc.2022.02.003","volume":"79","author":"TJ Gluckman","year":"2022","unstructured":"Gluckman, T. J., Bhave, N. M., Allen, L. A., Chung, E. H., Spatz, E. S., Ammirati, E., Baggish, A. L., Bozkurt, B., Cornwell, W. K., III., & Harmon, K. G. (2022). 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: Myocarditis and other myocardial involvement, post-acute Sequelae of SARS-CoV-2 infection, and return to play: A report of the American college of cardiology solution set oversight committee. Journal of the American College of Cardiology, 79(17), 1717\u20131756.","journal-title":"Journal of the American College of Cardiology"},{"key":"10001_CR7","doi-asserted-by":"crossref","unstructured":"Karthik, R., Soumya, M., Alagar R, M., Soundarya, K., Dhanendra, T., Tarek Mohamed, A.E.-A., Cristel, A., Yuyang, S., Manigandan, V., Travis R, M., Kevin, C., Rachel, T., Neelanjan, V., Gregory, A., Allen, A., Luis, M.-S., Wenli, Y., James D, S., Brij B, S., Subramanya, S., W Brian, R. and Muniswamy, M. (2022). SARS-CoV-2 infection enhances mitochondrial PTP complex activity to perturb cardiac energetics. iScience 25.","DOI":"10.1016\/j.isci.2021.103722"},{"issue":"9","key":"10001_CR8","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.3390\/v13091880","volume":"13","author":"HT Ho","year":"2021","unstructured":"Ho, H. T., Peischard, S., Strutz-Seebohm, N., Klingel, K., & Seebohm, G. (2021). Myocardial damage by SARS-CoV-2: Emerging mechanisms and therapies. Viruses, 13(9), 1880.","journal-title":"Viruses"},{"key":"10001_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/cvr\/cvab322","volume":"118","author":"H Br\u00e4uninger","year":"2022","unstructured":"Br\u00e4uninger, H., Stoffers, B., Fitzek, A., Mei\u00dfner, K., Aleshcheva, G., Schweizer, M., Weimann, J., Rotter, B., Warnke, S., Edler, C., Braun, F., Roedl, K., Scherschel, K., Escher, F., Kluge, S., Huber, T., Ondruschka, B., Schultheiss, H., Kirchhof, P., \u2026 Lindner, D. (2022). Cardiac SARS-CoV-2 infection is associated with pro-inflammatory transcriptomic alterations within the heart. Cardiovascular Research, 118, 542\u2013555.","journal-title":"Cardiovascular Research"},{"issue":"12","key":"10001_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/biomedicines8120626","volume":"8","author":"GP Bulfamante","year":"2020","unstructured":"Bulfamante, G. P., Perrucci, G. L., Falleni, M., Sommariva, E., Tosi, D., Martinelli, C., Songia, P., Poggio, P., Carugo, S., & Pompilio, G. (2020). Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement. Biomedicines, 8(12), 626.","journal-title":"Biomedicines"},{"issue":"09","key":"10001_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/CM9.0000000000000722","volume":"133","author":"LL Ren","year":"2020","unstructured":"Ren, L. L., Wang, Y. M., Wu, Z. Q., Xiang, Z. C., Guo, L., Xu, T., Jiang, Y. Z., Xiong, Y., Li, Y. J., Li, X. W., & Li, H. (2020). Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study. Chinese Medical Journal, 133(09), 1015\u20131024.","journal-title":"Chinese Medical Journal"},{"issue":"10224","key":"10001_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., & Bi, Y. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395(10224), 565\u2013574.","journal-title":"The Lancet"},{"issue":"1","key":"10001_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13046-024-03116-6","volume":"43","author":"L Li","year":"2024","unstructured":"Li, L., Liu, D., Chen, T., Wei, C., Qiao, Y., Liu, W., Liang, Y., Liang, Z., Chen, C., Li, D., & Wu, B. (2024). Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression. Journal of Experimental and Clinical Cancer Research, 43(1), 200.","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"issue":"1","key":"10001_CR14","first-page":"1","volume":"20","author":"J Yunlong","year":"2021","unstructured":"Yunlong, J., Cong, T., Hongyan, W., Fan, Y., Wei, L., Yuqing, D., Zishuo, C., Xuexiao, W., Yu, W., Tianxu, L., & Jiali, W. (2021). Long non-coding RNA NORAD\/miR-224-3p\/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of \u03b2-catenin. Molecular Cancer (Web), 20(1), 1\u201322.","journal-title":"Molecular Cancer (Web)"},{"issue":"10229","key":"10001_CR15","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., & Guan, L. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054\u20131062.","journal-title":"The Lancet"},{"key":"10001_CR16","unstructured":"Nathaniel R, S., Neil, J., Ji, C., Yindalon, A., Ruina, Z., Siddhant, D., Carlos L, A., Norma, K., Louai, R., Adriana, Q.-C., Albert S, J., Glenn I, F., Judith S, H. and Jeffrey S, B. (2020). Myocardial injury in adults hospitalized with COVID-19. Circulation 142."},{"issue":"7","key":"10001_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology, 5(7), 811\u2013818.","journal-title":"JAMA Cardiology"},{"key":"10001_CR18","doi-asserted-by":"publisher","first-page":"100950","DOI":"10.1016\/j.ijcha.2021.100950","volume":"40","author":"O Ogungbe","year":"2022","unstructured":"Ogungbe, O., Kumbe, B., Fadodun, O. A., Latha, T., Meyer, D., Asala, A. F., Davidson, P. M., Himmelfarb, C. R., Post, W. S., & Commodore-Mensah, Y. (2022). Subclinical myocardial injury, coagulopathy, and inflammation in COVID-19: A meta-analysis of 41013 hospitalized patients. IJC Heart and Vasculature, 40, 100950.","journal-title":"IJC Heart and Vasculature"},{"issue":"22","key":"10001_CR19","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/eurheartj\/ehaa408","volume":"41","author":"S Shi","year":"2020","unstructured":"Shi, S., Qin, M., Cai, Y., Liu, T., Shen, B., Yang, F., Cao, S., Liu, X., Xiang, Y., Zhao, Q., & Huang, H. (2020). Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. European Heart Journal, 41(22), 2070\u20132079.","journal-title":"European Heart Journal"},{"key":"10001_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacbts.2022.09.001","volume":"8","author":"B Brumback","year":"2023","unstructured":"Brumback, B., Dmytrenko, O., Robinson, A., Bailey, A., Ma, P., Liu, J., Hicks, S., Ng, S., Li, G., Zhang, D., Lipovsky, C., Lin, C., Diamond, M., Lavine, K., & Rentschler, S. (2023). Human cardiac pericytes are susceptible to SARS-CoV-2 infection. JACC. Basic to Translational Science, 8, 109\u2013120.","journal-title":"JACC. Basic to Translational Science"},{"issue":"2","key":"10001_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"H Markus","year":"2020","unstructured":"Markus, H., Hannah, K. W., Simon, S., Nadine, K., Tanja, H., Schiergens, S. E., Tobias, S., Herrler Georg, Wu., Nai-Huei, N. A., et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271\u2013280.","journal-title":"Cell"},{"issue":"3","key":"10001_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021). Coronavirus biology and replication: Implications for SARS-CoV-2. Nature Reviews Microbiology, 19(3), 155\u2013170.","journal-title":"Nature Reviews Microbiology"},{"key":"10001_CR23","doi-asserted-by":"publisher","first-page":"198897","DOI":"10.1016\/j.virusres.2022.198897","volume":"320","author":"M Upadhyay","year":"2022","unstructured":"Upadhyay, M., & Gupta, S. (2022). Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2. Virus Research, 320, 198897.","journal-title":"Virus Research"},{"issue":"3","key":"10001_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/10520295.2018.1535138","volume":"94","author":"A Maiese","year":"2019","unstructured":"Maiese, A., Bolino, G., Mastracchio, A., Frati, P., & Fineschi, V. (2019). An immunohistochemical study of the diagnostic value of TREM-1 as marker for fatal sepsis cases. Biotechnic and Histochemistry, 94(3), 159\u2013166.","journal-title":"Biotechnic and Histochemistry"},{"key":"10001_CR25","unstructured":"Ji-Qian, X., Wan-Ying, Z., Jia-Ji, F., Xiang-Zhi, F., Cheng-Gang, G., Chang, L., Lu, Y., Qi-Lan, L., Xiao-Bo, Y., Le-Hao, R., Hua-Qing, S., Ke, P., Ying, W., Ding-Yu, Z., Yang, Q., Xi, Z., Yong-Ming, Y. and You, S. (2024). Viral sepsis: Diagnosis, clinical features, pathogenesis, and clinical considerations. Mil Med Res 11."},{"issue":"10223","key":"10001_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., & Cheng, Z. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. The Lancet, 395(10223), 497\u2013506.","journal-title":"The Lancet"},{"key":"10001_CR27","first-page":"E005","volume":"43","author":"L Chen","year":"2020","unstructured":"Chen, L., Liu, H. G., Liu, W., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020). Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases, 43, E005.","journal-title":"Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases"},{"key":"10001_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ijid.2020.04.041","volume":"95","author":"Z Zhu","year":"2020","unstructured":"Zhu, Z., Cai, T., Fan, L., Lou, K., Hua, X., Huang, Z., & Gao, G. (2020). Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. International Journal of Infectious Diseases, 95, 332\u2013339.","journal-title":"International Journal of Infectious Diseases"},{"issue":"10","key":"10001_CR29","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M., Kim-Schulze, S., Huang, H. H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., & Marron, T. U. (2020). An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature Medicine, 26(10), 1636\u20131643.","journal-title":"Nature Medicine"},{"issue":"1","key":"10001_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/ijms22010321","volume":"22","author":"AC Manetti","year":"2020","unstructured":"Manetti, A. C., Maiese, A., Paolo, M. D., De Matteis, A., La Russa, R., Turillazzi, E., Frati, P., & Fineschi, V. (2020). MicroRNAs and Sepsis-induced cardiac dysfunction: A systematic review. International Journal of Molecular Sciences, 22(1), 321.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10001_CR31","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/bpa.13013","volume":"31","author":"A Maiese","year":"2021","unstructured":"Maiese, A., Manetti, A. C., Bosetti, C., Del Duca, F., La Russa, R., Frati, P., Di Paolo, M., Turillazzi, E., & Fineschi, V. (2021). SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathology, 31(6), e13013.","journal-title":"Brain Pathology"},{"key":"10001_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s43657-022-00066-x","volume":"2","author":"Z Feng","year":"2022","unstructured":"Feng, Z., Ren, X., Duren, Z., & Wang, Y. (2022). Human genetic variants associated with COVID-19 severity are enriched in immune and epithelium regulatory networks. Phenomics, 2, 389\u2013403.","journal-title":"Phenomics"},{"issue":"1","key":"10001_CR33","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1146\/annurev-immunol-032414-112227","volume":"33","author":"AA de Jesus","year":"2015","unstructured":"de Jesus, A. A., Canna, S. W., Liu, Y., & Goldbach-Mansky, R. (2015). Molecular mechanisms in genetically defined autoinflammatory diseases: Disorders of amplified danger signaling. Annual Review of Immunology, 33(1), 823\u2013874.","journal-title":"Annual Review of Immunology"},{"issue":"22","key":"10001_CR34","first-page":"2323","volume":"132","author":"DC Fajgenbaum","year":"2018","unstructured":"Fajgenbaum, D. C. (2018). Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood, The Journal of the American Society of Hematology, 132(22), 2323\u20132330.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"12","key":"10001_CR35","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.4049\/jimmunol.166.12.7617","volume":"166","author":"BT Fife","year":"2001","unstructured":"Fife, B. T., Kennedy, K. J., Paniagua, M. C., Lukacs, N. W., Kunkel, S. L., Luster, A. D., & Karpus, W. J. (2001). CXCL10 (IFN-\u03b3-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. The Journal of Immunology, 166(12), 7617\u20137624.","journal-title":"The Journal of Immunology"},{"issue":"7","key":"10001_CR36","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","volume":"168","author":"JH Dufour","year":"2002","unstructured":"Dufour, J. H., Dziejman, M., Liu, M. T., Leung, J. H., Lane, T. E., & Luster, A. D. (2002). IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. The Journal of Immunology, 168(7), 3195\u20133204.","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10001_CR37","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.4049\/jimmunol.177.5.3185","volume":"177","author":"JP Chen","year":"2006","unstructured":"Chen, J. P., Lu, H. L., Lai, S. L., Campanella, G. S., Sung, J. M., Lu, M. Y., Wu-Hsieh, B. A., Lin, Y. L., Lane, T. E., Luster, A. D., & Liao, F. (2006). Dengue virus induces expression of CXC chemokine ligand 10\/IFN-\u03b3-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. The Journal of Immunology, 177(5), 3185\u20133192.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10001_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40779-024-00588-7","volume":"12","author":"BF Tang","year":"2025","unstructured":"Tang, B. F., Xu, W. T., Fang, S. J., Zhu, J. Y., Qiu, R. F., Shen, L., Yang, Y., Weng, Q. Y., Wang, Y. J., Ding, J. Y., & Zhang, X. J. (2025). MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies. Military Medical Research, 12(1), 5.","journal-title":"Military Medical Research"},{"issue":"6","key":"10001_CR39","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.4049\/jimmunol.175.6.3516","volume":"175","author":"A Rhode","year":"2005","unstructured":"Rhode, A., Pauza, M. E., Barral, A. M., Rodrigo, E., Oldstone, M., von Herrath, M. G., & Christen, U. (2005). Islet-specific expression of CXCL10 causes spontaneous islet infiltration and accelerates diabetes development. The Journal of Immunology, 175(6), 3516\u20133524.","journal-title":"The Journal of Immunology"},{"key":"10001_CR40","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1128\/JVI.73.2.1479-1491.1999","volume":"73","author":"S Mahalingam","year":"1999","unstructured":"Mahalingam, S., Farber, J., & Karupiah, G. (1999). The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity In vivo. Journal of Virology, 73, 1479\u20131491.","journal-title":"Journal of Virology"},{"key":"10001_CR41","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1128\/MCB.25.14.6247-6258.2005","volume":"25","author":"H Zhang","year":"2005","unstructured":"Zhang, H., Yuan, J., Cheung, P., Chau, D., Wong, B., McManus, B., & Yang, D. (2005). Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression. Molecular and Cellular Biology, 25, 6247\u20136258.","journal-title":"Molecular and Cellular Biology"},{"key":"10001_CR42","doi-asserted-by":"crossref","unstructured":"Majumdar, S., Weaver, J., Pontejo, S., Minai, M., Lu, X., Gao, J., Holmes, G., Johnson, R., Zhang, H., Kelsall, B., Farber, J., Alves, D. and Murphy, P. (2024). Cxcl10 is required for survival during SARS-CoV-2 infection in mice. bioRxiv: The preprint server for biology.","DOI":"10.1101\/2024.09.30.613319"},{"issue":"3","key":"10001_CR43","doi-asserted-by":"publisher","first-page":"qiae252","DOI":"10.1093\/jleuko\/qiae252","volume":"117","author":"S Majumdar","year":"2025","unstructured":"Majumdar, S., Weaver, J. D., Pontejo, S. M., Minai, M., Lu, X., Gao, J. L., Holmes, G., Johnson, R., Zhang, H., Kelsall, B. L., & Farber, J. M. (2025). Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection. Journal of Leukocyte Biology, 117(3), qiae252.","journal-title":"Journal of Leukocyte Biology"},{"issue":"6","key":"10001_CR44","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/v13061062","volume":"13","author":"V Callahan","year":"2021","unstructured":"Callahan, V., Hawks, S., Crawford, M. A., Lehman, C. W., Morrison, H. A., Ivester, H. M., Akhrymuk, I., Boghdeh, N., Flor, R., Finkielstein, C. V., & Allen, I. C. (2021). The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are upregulated following SARS-CoV-2 infection in an AKT-Dependent manner. Viruses, 13(6), 1062.","journal-title":"Viruses"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-025-10001-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-025-10001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:02:12Z","timestamp":1748365332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-025-10001-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10001"],"URL":"https:\/\/doi.org\/10.1007\/s12012-025-10001-x","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}